fbpx
Refer an Agent
Medicare Industry Update – Aduhelm

Medicare Industry Update - New Alzheimer’s Drug Aduhelm

CMS Proposes Medicare Coverage Policy for Aduhelm for the treatment of Alzheimer’s Disease; which means the FDA-approved drug will be covered for people with Medicare, but only if they are enrolled in qualifying clinical trials. 

For more information you can read the full CMS press release here. 

Have questions about Aduhelm or how Medicare premiums could be affected? Call us at 800-268-2800.

Facebook Linkedin Youtube Twitter Instagram

Sources:

https://www.kff.org/policy-watch/medicares-coverage-decision-for-the-new-alzheimers-drug-and-why-it-matters/#:~:text=Back%20in%20November%202021%2C%20prior,Part%20B%20premium%20for%202022

https://www.cms.gov/newsroom/press-releases/cms-proposes-medicare-coverage-policy-monoclonal-antibodies-directed-against-amyloid-treatment

https://www.fiercehealthcare.com/payer/lawmakers-ratchet-up-pressure-cms-to-change-part-b-premiums-after-aduhelm-price-drop

 

Recent Posts

AMP, Agent Marketing Portfolio

The Agent Marketing Portfolio (AMP) catalog is an exclusive offer to contracted agents.

Order your custom personalized marketing pieces today! 

Amplify Your Marketing Strategy Here!

Sidebar Setup


Please add widgets to the sidebar to have them display here.

View details »

Quote Engine

Election Period Assistance

Medicare Cafe

CARE Initiative

70% shopping rates will make this AEP a war zone. Do you have your Battle Plan ready?

Attend one of our in-person AEP Disruptions Bootcamps, or be left behind.

July 23, 2024 
Blue Springs, MO

July 25, 2024
St. Charles, MO

July 31, 2024
Columbia, MO

RSVP NOW

Sign In

Your username is the email you registered with.